Search

everythinglearnresearchcommunity

for

Search:↓

Using iontophoresis on minoxidil sulphate-loaded chitosan nanoparticles increases drug release but reduces its targeting to hair follicles.

Scalp hair thinning in women with PCOS is linked to metabolic issues like abnormal glucose tolerance, high LDL, and skipped meals.

Societal pressure for the perfect body leads to health risks and disorders.

New oral treatment, finasteride, effectively and safely treats common hair loss.

Tildrakizumab may cause alopecia areata, but stopping it and using corticosteroids can regrow hair.

Understanding how mesenchymal stem cells stay undifferentiated can improve their use in treating diseases.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Sex hormones do not cause oral lichen planus.

Hair density decreases with age, especially in the 60s.

Diseases have a big social impact in Nordic countries, affecting healthcare decisions.

Ozone and procaine boost the release of healing factors in platelet-rich plasma.

Tofu whey improves foot skin health and supports sustainable cosmetics.

Alopecia after COVID-19 negatively impacts quality of life, especially vitality.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

Apremilast shows promise for several skin conditions but needs more research.

Lower BDNF levels link to worse depression in alopecia areata patients.

Possible endocrine disorders caused woman's hair loss and obesity in painting.

Women with cicatricial hair loss may have a higher risk of hypertension.

Better hair loss models needed for research.

Premature graying of hair significantly harms psychological and social wellbeing.

Artificial hair implants can quickly improve looks and life quality, but they have risks like infection and early fiber loss, so more research is needed to confirm their safety and effectiveness.

Balding might help identify men at higher risk for severe COVID-19, but more research is needed.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

Old drugs like finasteride and spironolactone are being successfully used for hair loss and skin conditions, and many other drugs show promise for new uses in dermatology.

Botulinum toxin may help treat hair loss by relaxing scalp muscles, improving oxygen and blood flow.

Most patients successfully switched from the original adalimumab to a biosimilar with few reverting due to reduced effectiveness or side effects.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Men with thinner hair from genetic hair loss may be more likely to have an enlarged prostate.

Sebaceous glands are often preserved and PPARy expression is constant in some cases of Central Centrifugal Cicatricial Alopecia.

People with male pattern baldness are more likely to have metabolic syndrome.